Published in Kidney Int on May 01, 1991
Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun (2009) 1.07
Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated? Pediatr Nephrol (2005) 0.95
Complement Activation in Patients with Focal Segmental Glomerulosclerosis. PLoS One (2015) 0.85
Nephrology, dialysis and transplantation. Postgrad Med J (1993) 0.75
Diffuse mesangial and endocapillary cell proliferative glomerulonephritis with persistent hypocomplementemia in a child. Int J Clin Exp Med (2015) 0.75
Therapeutic regulation of complement in patients with renal disease - where is the promise? Clin Nephrol (2012) 0.75
A wolf in another wolf's clothing. IDCases (2017) 0.75
Long-term follow-up of juvenile acute nonproliferative glomerulitis (JANG). Pediatr Nephrol (2007) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Rituximab treatment of idiopathic membranous nephropathy. Kidney Int (2007) 2.85
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant (2013) 2.35
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
The impact of boreal forest fire on climate warming. Science (2006) 2.08
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant (2011) 1.98
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (2009) 1.71
Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant (2006) 1.70
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant (2007) 1.25
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
The earliest stages of ecosystem succession in high-elevation (5000 metres above sea level), recently deglaciated soils. Proc Biol Sci (2008) 1.23
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant (2007) 1.19
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol (1983) 1.13
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant (2008) 1.07
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol (1991) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int (1992) 1.00
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Circulation (1993) 0.97
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97
Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules. Kidney Int (1996) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology (1981) 0.95
Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J Immunol (1990) 0.95
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant (2012) 0.93
Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy. Am J Nephrol (1999) 0.93
Immunosuppressive effects of pentostatin. J Clin Oncol (1990) 0.93
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92
Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant (2008) 0.92
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Severe renal failure in multiple myeloma. Clin Nephrol (1981) 0.92
Obese living kidney donors: short-term results and possible implications. Transplantation (1999) 0.92
Fragmented electrograms and continuous electrical activity in atrial flutter. Am J Cardiol (1986) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
Characterization of the baboon erythrocyte C3b-binding protein. J Immunol (1989) 0.91
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes. J Lab Clin Med (1984) 0.90
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90
Use of indirect immunofluorescence in the lupus erythematosus/lichen planus overlap syndrome: an additional diagnostic clue. J Am Acad Dermatol (1984) 0.90
Atheroembolic renal disease causes hypocomplementaemia. Lancet (1985) 0.89
Living donor age and kidney transplant outcomes. Am J Transplant (2011) 0.88
Binding of human fibronectin to antigen-antibody complexes. J Lab Clin Med (1986) 0.88
Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation (1996) 0.86
Posttransplant lymphoproliferative disorder following pancreas transplantation. Am J Transplant (2009) 0.86
Kidney allograft inflammation and fibrosis, causes and consequences. Am J Transplant (2012) 0.86
Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome. Am J Cardiol (1982) 0.86
Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis (2001) 0.86
Immune regulation of immunoglobulin production in IgA-nephropathy. Clin Immunol Immunopathol (1982) 0.85
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85
Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy. Am J Transplant (2015) 0.85
Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int (1981) 0.84
Increased helper-suppressor T-cell ratio in psoriasis. Arch Dermatol (1982) 0.84
Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84
Combined nephrotoxic effects of cyclosporine and endotoxin. Transplantation (1987) 0.84
Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med (1985) 0.83
Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant (2009) 0.83
Binding of soluble immune complexes by human monocytes and pulmonary macrophages: effects of cigarette smoking. J Lab Clin Med (1982) 0.83
Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res (2001) 0.83
Polyomavirus-associated nephropathy risk in kidney transplants: the influence of recipient age and donor gender. Kidney Int (2007) 0.83
The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation. Am J Transplant (2010) 0.83
Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med (1979) 0.83
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int (1998) 0.83
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment. JAMA (1982) 0.82